PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Sep-2024 CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress AccessWire
13-Sep-2024 Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024 AccessWire
13-Sep-2024 Ensysce Biosciences Posts Video Updates from the IASP World Congress on Pain 2024 AccessWire
13-Sep-2024 CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress CureVac
13-Sep-2024 Clinical Research Training: Your Path to a Successful Career Fusion technology solutions
13-Sep-2024 ISO 9001-Certified Chromatography Media from Amerigo Scientific to Facilitate Mixture Purification Amerigo Scientific
13-Sep-2024 2024 PM Society Digital Award Winners PM Society
13-Sep-2024 Tenon Medical, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules AccessWire
13-Sep-2024 Tenon(R) Medical Announces the Introduction of the Catamaran(R) SE SI Joint Fusion System AccessWire
12-Sep-2024 The Spero Clinic: A Breakthrough in Complex Regional Pain Syndrome Treatment AccessWire
12-Sep-2024 Teilnahme an der Investora am 19. September 2024 und frühere Publikation des Halbjahresreports am 16. September Curatis Holding AG
12-Sep-2024 Jacksonville Medical Waste Disposal Experts Confront Surge in Needlestick Injuries With Comprehensive Guide AccessWire
12-Sep-2024 Medacta Introduces a Simplified Approach for the M-ARS ACL Technique at the AGA Congress 2024, Mimicking the Native Ligament Footprint with an Optimized Surgical Flow Medacta Group SA
12-Sep-2024 AGS Health Earns Great Place To Work Certification(TM) AccessWire
12-Sep-2024 RYBREVANT®▼ (amivantamab) plus lazertinib shows favourable overall survival trend in EGFR-mutated advanced non-small cell lung cancer (NSCLC) compared to osimertinib Johnson & Johnson
12-Sep-2024 NHSBSA releases latest mental health medicines statistics NHSBSA
12-Sep-2024 Aston University pharmacy team shortlisted for Times Higher Education award Aston University
12-Sep-2024 Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial Gilead’s
12-Sep-2024 Mentavi Health Launches the Mental Wellness Snapshot, an Evidence-Based Tool for Preventative Mental Health AccessWire
12-Sep-2024 Alchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer Alchemab